Last reviewed · How we verify
Hair-X Hair Loss Relief (SELENIUM)
SELENIUM (Hair-X Hair Loss Relief) is a marketed product by Chattem designed to stimulate hair growth, though its exact mechanism remains unknown. The key composition patent is set to expire in 2028, providing a clear timeline for potential generic competition. The primary risk lies in the lack of specified primary indication and key trial results, which may limit its market differentiation and regulatory support.
At a glance
| Generic name | SELENIUM |
|---|---|
| Sponsor | Chattem |
| Drug class | Non-Standardized Fungal Allergenic Extract [EPC] |
| Modality | Small molecule |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
| First approval | 1997 |
Approved indications
- Not Specified
Common side effects
Key clinical trials
- Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies (PHASE2)
- Tuna Based Nuggets and Ischemic Cardiomyopathy (NA)
- A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on Abnormal Cervical Cells Caused by HPV. (NA)
- Evaluation of the Benefits of Shampoo During 4 Weeks of Treatment and After 24 Weeks
- Evaluation and Comparison of the Benefits of Routine vs Shampoo Alone During 4 Weeks Treatment and 12 Weeks Remanence
- Assessing the Impact of Herbal Supplement on Fatigue and Disease Activity in SLE: Results From an 8-Week Randomized Trial (NA)
- Alii Supplement Study (PHASE2)
- Chemo Brain Prehab Project (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Hair-X Hair Loss Relief CI brief — competitive landscape report
- Hair-X Hair Loss Relief updates RSS · CI watch RSS
- Chattem portfolio CI